Weber Kathleen Gallagher 4
4 · ORASURE TECHNOLOGIES INC · Filed Dec 21, 2023
Insider Transaction Report
Form 4
Weber Kathleen Gallagher
Chief Product Officer
Transactions
- Exercise/Conversion
Common Stock
2023-12-19$5.71/sh+4,129$23,597→ 278,829 total - Sale
Common Stock
2023-12-19$8.05/sh−24,129$194,219→ 254,700 total - Exercise/Conversion
Non-Qualified Stock Options
2023-12-19−4,129→ 0 totalExercise: $5.71Exp: 2024-02-03→ Common Stock (4,129 underlying)
Footnotes (3)
- [F1]The reported transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 25, 2023.
- [F2]The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.095, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Non-qualified stock options granted on February 3, 2014, vesting 25% at the end of 12 months after the grant date and 75% ratably on a monthly basis over the next 36 months. Vesting shall cease upon voluntary termination of employment.